Fluid accumulation within the PERICARDIUM. Serous effusions are associated with pericardial diseases. Hemopericardium is associated with trauma. Lipid-containing effusion (chylopericardium) results from leakage of THORACIC DUCT. Severe cases can lead to CARDIAC TAMPONADE.
Compression of the heart by accumulated fluid (PERICARDIAL EFFUSION) or blood (HEMOPERICARDIUM) in the PERICARDIUM surrounding the heart. The affected cardiac functions and CARDIAC OUTPUT can range from minimal to total hemodynamic collapse.
Puncture and aspiration of fluid from the PERICARDIUM.
Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself.
Inflammation of the PERICARDIUM from various origins, such as infection, neoplasm, autoimmune process, injuries, or drug-induced. Pericarditis usually leads to PERICARDIAL EFFUSION, or CONSTRICTIVE PERICARDITIS.
Surgical construction of an opening or window in the pericardium. It is often called subxiphoid pericardial window technique.
INFLAMMATION of the sac surrounding the heart (PERICARDIUM) due to MYCOBACTERIUM TUBERCULOSIS infection. Pericarditis can lead to swelling (PERICARDIAL EFFUSION), compression of the heart (CARDIAC TAMPONADE), and preventing normal beating of the heart.
Surgical excision (total or partial) of a portion of the pericardium. Pericardiotomy refers to incision of the pericardium.
Presence of fluid in the PLEURAL CAVITY as a complication of malignant disease. Malignant pleural effusions often contain actual malignant cells.
A conical fibro-serous sac surrounding the HEART and the roots of the great vessels (AORTA; VENAE CAVAE; PULMONARY ARTERY). Pericardium consists of two sacs: the outer fibrous pericardium and the inner serous pericardium. The latter consists of an outer parietal layer facing the fibrous pericardium, and an inner visceral layer (epicardium) resting next to the heart, and a pericardial cavity between these two layers.
The removal of fluids or discharges from the body, such as from a wound, sore, or cavity.
Inflammation of the PERICARDIUM that is characterized by the fibrous scarring and adhesion of both serous layers, the VISCERAL PERICARDIUM and the PARIETAL PERICARDIUM leading to the loss of pericardial cavity. The thickened pericardium severely restricts cardiac filling. Clinical signs include FATIGUE, muscle wasting, and WEIGHT LOSS.
An opaque, milky-white fluid consisting mainly of emulsified fats that passes through the lacteals of the small intestines into the lymphatic system.
Tumors in any part of the heart. They include primary cardiac tumors and metastatic tumors to the heart. Their interference with normal cardiac functions can cause a wide variety of symptoms including HEART FAILURE; CARDIAC ARRHYTHMIAS; or EMBOLISM.
Also called xiphoid process, it is the smallest and most inferior triangular protrusion of the STERNUM or breastbone that extends into the center of the ribcage.
Inflammation of the middle ear with a clear pale yellow-colored transudate.
Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic.
The administration of therapeutic agents drop by drop, as eye drops, ear drops, or nose drops. It is also administered into a body space or cavity through a catheter. It differs from THERAPEUTIC IRRIGATION in that the irrigate is removed within minutes, but the instillate is left in place.
General or unspecified injuries to the heart.
Injection of air or a more slowly absorbed gas such as nitrogen, into the PLEURAL CAVITY to collapse the lung.
X-ray visualization of the chest and organs of the thoracic cavity. It is not restricted to visualization of the lungs.
A nonspecific hypersensitivity reaction caused by TRAUMA to the PERICARDIUM, often following PERICARDIOTOMY. It is characterized by PERICARDIAL EFFUSION; high titers of anti-heart antibodies; low-grade FEVER; LETHARGY; loss of APPETITE; or ABDOMINAL PAIN.
Inorganic compounds that contain chromium as an integral part of the molecule.
A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)
A congenital abnormality characterized by the elevation of the DIAPHRAGM dome. It is the result of a thinned diaphragmatic muscle and injured PHRENIC NERVE, allowing the intra-abdominal viscera to push the diaphragm upward against the LUNG.
Endoscopic surgery of the pleural cavity performed with visualization via video transmission.
Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.
Exudates are fluids, CELLS, or other cellular substances that are slowly discharged from BLOOD VESSELS usually from inflamed tissues. Transudates are fluids that pass through a membrane or squeeze through tissue or into the EXTRACELLULAR SPACE of TISSUES. Transudates are thin and watery and contain few cells or PROTEINS.
Tuberculosis of the serous membrane lining the thoracic cavity and surrounding the lungs.
A rare neoplasm of large B-cells usually presenting as serious effusions without detectable tumor masses. The most common sites of involvement are the pleural, pericardial, and peritoneal cavities. It is associated with HUMAN HERPESVIRUS 8, most often occurring in the setting of immunodeficiency.
Broad spectrum antinematodal anthelmintic used also in veterinary medicine.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
INFLAMMATION of PLEURA, the lining of the LUNG. When PARIETAL PLEURA is involved, there is pleuritic CHEST PAIN.
A pouch or sac developed from a tubular or saccular organ, such as the GASTROINTESTINAL TRACT.

Differential diagnostic significance of the paucity of HLA-I antigens on metastatic breast carcinoma cells in effusions. (1/578)

Distinction between benign reactive mesothelial cells and metastatic breast adenocarcinoma cells in effusions from patients with a known prior history of breast cancer is not the easiest task in diagnostic pathology. Here, we report the usefulness of testing the expression of class I HLA antigens (HLA A, B, C) in this respect. Cytospins were prepared from effusions of patients without the history of breast cancer (5 cases) and from effusions of patients with infiltrating ductal carcinoma (11 cases). Three effusions from cancerous patients were not malignant cytologically. The expression of HLA-A, B, C, HLA-DR and beta2-microglobulin as well as the macrophage antigen, CD14, was evaluated by immunocytochemistry. In 10 of 11 effusions the cytologically malignant cells expressed very weak or undetectable HLA-A,B,C as compared to the mesothelial cells and macrophages. The paucity of expression of HLA-A, B, C was detectable in those 3 cases where a definitive cytological diagnosis of malignancy could not be established. In contrast, mesothelial cells and macrophages from all samples were uniformly and strongly positive for both HLA-A, B, C and beta2-microglobulin. We conclude that the paucity of HLA-I antigens provides a marker helpful in distinguishing metastatic breast carcinoma cells from reactive mesothelial cells in effusions.  (+info)

Isolated primary chylopericardium. (2/578)

A 16-year-old man was found to have an enlarged cardiac silhouette. Primary chylopericardium was diagnosed when pericardiocentesis yielded the characteristic milky-white fluid. The thoracic duct was easily identified by giving milk and butter and an injection of ethylene blue immediately before the operation. Intraoperative thoracic ductography showed no abnormal findings. Mass ligation of the thoracic duct above the diaphragm and partial pericardiectomy were successfully performed through a right thoracotomy approach. In addition, many of the lymphatics were ligated above the diaphragm. The right thoracotomy approach was a useful method for resection and ligation of the thoracic duct just above the diaphragm. Follow-up showed no accumulation of pericardial fluid or pleural effusion.  (+info)

Recurrent pericardial effusion: the value of polymerase chain reaction in the diagnosis of tuberculosis. (3/578)

A 23 year old army man presented with progressive dyspnoea and was found to have a massive pericardial effusion. Despite extensive investigations the cause remained elusive, until samples were sent for polymerase chain reaction (PCR). This case was unusual for several reasons and is a reminder of the atypical way in which tuberculosis infection can present and how a high index of suspicion should be maintained. It shows the importance of molecular biological advances in providing simple and rapid methods for arriving at the correct diagnosis, by way of nucleic acid probes and polymerase chain reaction.  (+info)

Chylothorax, chylopericardium and lymphoedema--the presenting features of signet-ring cell carcinoma. (4/578)

This report describes a patient with chylous pleural and pericardial effusions in conjunction with severe lymphoedema resembling elephantiasis. The chylous effusions and generalized lymphoedema were associated with a signet-ring cell carcinoma.  (+info)

Treatment of malignant pericardial effusion with 32P-colloid. (5/578)

Malignant pericardial effusion is usually treated only when signs of cardiac tamponade develop. Several methods of treatment have been reported with an overall response rate of approximately 75%. Since our initial study using intrapericardial 32P-colloid instillation as a treatment modality for pericardial effusion demonstrated a significant higher response rate, this study was conducted to further evaluate the efficacy of intrapericardial 32P-colloid in terms of response rates and duration of remissions. Intrapericardial instillation of 185-370 MBq (5-10 mCi) 32P-colloid in 36 patients with malignant pericardial effusion resulted in a complete remission rate of 94.5% (34 patients) whereas two patients did not respond to treatment due to a foudroyant formation of pericardial fluid. The median duration time was 8 months. No side-effects were observed. These results suggest that intrapericardial instillation of 32P-colloid is a simple, reliable and safe treatment strategy for patients with malignant pericardial effusions. Therefore, since further evidence is provided that 32P-colloid is significantly more effective than external radiation or non-radioactive sclerosing agents, this treatment modality should be considered for the management of malignant pericardial effusion.  (+info)

Primary cardiac angiosarcoma associated with cardiac tamponade: case report. (6/578)

A 57-year-old male with primary cardiac angiosarcoma was initially admitted for cardiac tamponade. Pericardiocentesis was performed twice preoperatively, but the bloody pericardial fluid was cytologically negative for malignant cells. The tumor in the right atrium was resected during cardiopulmonary bypass. The resected tumor was 5.5x4.5x3.0cm in size and the diagnosis of cardiac angiosarcoma was made histologically. There were no tumor cells in the surgical margin. Unfortunately the patient died 3.5 months after surgery due to multiple recurrence in the pericardium. A suitable therapy for cardiac angiosarcoma is still controversial, but early antemortem diagnosis and more aggressive combined treatment should be considered.  (+info)

A case of prominent epicardial fat mimicking a tumor on echocardiography. (7/578)

Epicardial fat may anteriorly produce an echo-free space that can be mistaken for pericardial fluid. We recently experienced a 67-year-old woman with prominent epicardial fat which was presented as an echogenic tumor-like mass. She underwent open pericardiostomy to relieve large amount of pericardial effusion. Operative findings revealed only prominent epicardial fat. Biopsy of the pericardial and fat tissues revealed an inflammation and normal fat cells without any malignant cell infiltration.  (+info)

Risks of spontaneous injury and extraction of an active fixation pacemaker lead: report of the Accufix Multicenter Clinical Study and Worldwide Registry. (8/578)

BACKGROUND: The Telectronics Accufix pacing leads were recalled in November 1994 after 2 deaths and 2 nonfatal injuries were reported. This multicenter clinical study (MCS) of patients with Accufix leads was designed to determine the rate of spontaneous injury related to the J retention wire and results of lead extraction. METHODS AND RESULTS: The MCS included 2589 patients with Accufix atrial pacing leads that were implanted at or who were followed up at 12 medical centers. Patients underwent cinefluoroscopic imaging of their lead every 6 months. The risk of J retention wire fracture was approximately 5.6%/y at 5 years and 4.7%/y at 10 years after implantation. The annual risk of protrusion was 1.5%. A total of 40 spontaneous injuries were reported to a worldwide registry (WWR) that included data from 34 672 patients (34 892 Accufix leads), including pericardial tamponade (n=19), pericardial effusion (n=5), atrial perforation (n=3), J retention wire embolization (n=4), and death (n=6). The risk of injury was 0.02%/y (95% CI, 0.0025 to 0. 072) in the MCS and 0.048%/y (95% CI, 0.035 to 0.067) in the WWR. A total of 5299 leads (13%) have been extracted worldwide. After recall in the WWR, fatal extraction complications occurred in 0.4% of intravascular procedures (16 of 4023), with life-threatening complications in 0.5% (n=21). Extraction complications increased with implant duration, female sex, and J retention wire protrusion. CONCLUSIONS: Accufix pacing leads pose a low, ongoing risk of injury. Extraction is associated with substantially higher risks, and a conservative management approach is indicated for most patients.  (+info)

Pericardial effusion is an abnormal accumulation of fluid in the pericardial space, which is the potential space between the two layers of the pericardium - the fibrous and serous layers. The pericardium is a sac that surrounds the heart to provide protection and lubrication for the heart's movement during each heartbeat. Normally, there is only a small amount of fluid (5-15 mL) in this space to ensure smooth motion of the heart. However, when an excessive amount of fluid accumulates, it can cause increased pressure on the heart, leading to various complications such as decreased cardiac output and even cardiac tamponade, a life-threatening condition that requires immediate medical attention.

Pericardial effusion may result from several causes, including infections (viral, bacterial, or fungal), inflammatory conditions (such as rheumatoid arthritis, lupus, or cancer), trauma, heart surgery, kidney failure, or iatrogenic causes. The symptoms of pericardial effusion can vary depending on the rate and amount of fluid accumulation. Slowly developing effusions may not cause any symptoms, while rapid accumulations can lead to chest pain, shortness of breath, cough, palpitations, or even hypotension (low blood pressure). Diagnosis is usually confirmed through imaging techniques such as echocardiography, CT scan, or MRI. Treatment depends on the underlying cause and severity of the effusion, ranging from close monitoring to drainage procedures or medications to address the root cause.

Cardiac tamponade is a serious medical condition that occurs when there is excessive fluid or blood accumulation in the pericardial sac, which surrounds the heart. This accumulation puts pressure on the heart, preventing it from filling properly and reducing its ability to pump blood effectively. As a result, cardiac output decreases, leading to symptoms such as low blood pressure, shortness of breath, chest pain, and a rapid pulse. If left untreated, cardiac tamponade can be life-threatening, requiring emergency medical intervention to drain the fluid and relieve the pressure on the heart.

Pericardiocentesis is a medical procedure where a needle or a catheter is inserted into the pericardial sac, the thin fluid-filled space surrounding the heart, to remove excess fluids or air that has accumulated. This buildup can put pressure on the heart and impede its function, leading to various cardiac symptoms such as chest pain, shortness of breath, and palpitations. The procedure is often guided by echocardiography or fluoroscopy to ensure proper placement and minimize risks. Pericardiocentesis may be performed as an emergency treatment or a scheduled intervention, depending on the patient's condition.

Pleural effusion is a medical condition characterized by the abnormal accumulation of fluid in the pleural space, which is the thin, fluid-filled space that surrounds the lungs and lines the inside of the chest wall. This space typically contains a small amount of fluid to allow for smooth movement of the lungs during breathing. However, when an excessive amount of fluid accumulates, it can cause symptoms such as shortness of breath, coughing, and chest pain.

Pleural effusions can be caused by various underlying medical conditions, including pneumonia, heart failure, cancer, pulmonary embolism, and autoimmune disorders. The fluid that accumulates in the pleural space can be transudative or exudative, depending on the cause of the effusion. Transudative effusions are caused by increased pressure in the blood vessels or decreased protein levels in the blood, while exudative effusions are caused by inflammation, infection, or cancer.

Diagnosis of pleural effusion typically involves a physical examination, chest X-ray, and analysis of the fluid in the pleural space. Treatment depends on the underlying cause of the effusion and may include medications, drainage of the fluid, or surgery.

Pericarditis is a medical condition characterized by inflammation of the pericardium, which is the thin sac-like membrane that surrounds the heart and contains serous fluid to reduce friction during heartbeats. The inflammation can cause symptoms such as chest pain, shortness of breath, and sometimes fever.

The pericardium has two layers: the visceral pericardium, which is tightly adhered to the heart's surface, and the parietal pericardium, which lines the inner surface of the chest cavity. Normally, there is a small amount of fluid between these two layers, allowing for smooth movement of the heart within the chest cavity.

In pericarditis, the inflammation causes the pericardial layers to become irritated and swollen, leading to an accumulation of excess fluid in the pericardial space. This can result in a condition called pericardial effusion, which can further complicate the situation by putting pressure on the heart and impairing its function.

Pericarditis may be caused by various factors, including viral or bacterial infections, autoimmune disorders, heart attacks, trauma, or cancer. Treatment typically involves addressing the underlying cause, managing symptoms, and reducing inflammation with medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, or corticosteroids. In severe cases, pericardiocentesis (removal of excess fluid from the pericardial space) or surgical intervention may be necessary.

A pericardial window technique is a surgical procedure that creates an opening or window in the pericardium, which is the sac-like membrane surrounding the heart. This procedure is typically performed to relieve excessive pressure on the heart caused by excess fluid accumulation in the pericardial space (pericardial effusion) or to obtain tissue samples for diagnostic purposes.

There are two primary approaches to creating a pericardial window:

1. Surgical Pericardial Window: This is an open surgical procedure, usually performed under general anesthesia. The surgeon makes an incision in the chest wall and then opens the pericardium to create a window. Excess fluid is drained from the pericardial space, and the pericardial edges are sutured together to keep the window open. This technique allows for continuous drainage of any future fluid accumulation.

2. Percutaneous Pericardial Window: This is a minimally invasive procedure that involves inserting a needle or catheter through the skin and into the pericardial space under local anesthesia and image guidance (fluoroscopy, echocardiography, or CT scan). A guidewire is then passed through the needle, followed by a dilator and sheath. A drainage catheter is placed through the sheath into the pericardial space to remove excess fluid. The catheter may be left in place for several days to allow for continued drainage.

Pericardial window techniques are used to treat various conditions, including cardiac tamponade (life-threatening compression of the heart due to pericardial effusion), infectious pericarditis, malignant pericardial effusions, and inflammatory disorders affecting the pericardium.

Tuberculous pericarditis is a specific form of pericarditis (inflammation of the pericardium, the thin sac-like membrane that surrounds the heart) that is caused by the bacterial infection of Mycobacterium tuberculosis. This type of pericarditis is more common in areas where tuberculosis is prevalent and can lead to serious complications if not diagnosed and treated promptly.

In tuberculous pericarditis, the bacteria typically spread from the lungs (the most common site of TB infection) or other infected organs through the bloodstream to the pericardium. The infection causes an inflammatory response, leading to the accumulation of fluid in the pericardial space (pericardial effusion), which can put pressure on the heart and impair its function. In some cases, the inflammation may lead to the formation of scar tissue, causing the pericardium to thicken and constrict, a condition known as constrictive pericarditis.

Symptoms of tuberculous pericarditis can include chest pain, cough, fever, fatigue, weight loss, and difficulty breathing. Diagnosis typically involves a combination of medical history, physical examination, imaging tests (such as echocardiography, CT scan, or MRI), and laboratory tests (including analysis of the pericardial fluid). Treatment usually consists of a long course of antibiotics specific to TB, along with anti-inflammatory medications and close monitoring for potential complications.

Pericardiectomy is a surgical procedure that involves the removal of all or part of the pericardium, which is the sac-like membrane surrounding the heart. This surgery is typically performed to treat chronic or recurrent pericarditis, constrictive pericarditis, or pericardial effusions that do not respond to other treatments. Pericardiectomy can help reduce symptoms such as chest pain, shortness of breath, and fluid buildup around the heart, improving the patient's quality of life and overall prognosis.

Malignant pleural effusion is a medical condition characterized by the abnormal accumulation of fluid in the pleural space (the area between the lungs and the chest wall) due to the spread of malignant (cancerous) cells from a primary tumor located elsewhere in the body. This type of effusion is typically associated with advanced-stage cancer, and it can cause symptoms such as shortness of breath, coughing, and chest pain. The presence of malignant pleural effusion often indicates a poor prognosis, and treatment is generally focused on palliating symptoms and improving quality of life.

The pericardium is the double-walled sac that surrounds the heart. It has an outer fibrous layer and an inner serous layer, which further divides into two parts: the parietal layer lining the fibrous pericardium and the visceral layer (epicardium) closely adhering to the heart surface.

The space between these two layers is filled with a small amount of lubricating serous fluid, allowing for smooth movement of the heart within the pericardial cavity. The pericardium provides protection, support, and helps maintain the heart's normal position within the chest while reducing friction during heart contractions.

Drainage, in medical terms, refers to the removal of excess fluid or accumulated collections of fluids from various body parts or spaces. This is typically accomplished through the use of medical devices such as catheters, tubes, or drains. The purpose of drainage can be to prevent the buildup of fluids that may cause discomfort, infection, or other complications, or to treat existing collections of fluid such as abscesses, hematomas, or pleural effusions. Drainage may also be used as a diagnostic tool to analyze the type and composition of the fluid being removed.

Constrictive pericarditis is a medical condition characterized by the inflammation and thickening of the pericardium, which is the sac-like membrane that surrounds the heart. This inflammation leads to scarring and thickening of the pericardium, causing it to become stiff and inflexible. As a result, the heart's ability to fill with blood between beats is restricted, leading to symptoms such as shortness of breath, fatigue, and fluid retention.

In contrastive pericarditis, the thickened and scarred pericardium restricts the normal movement of the heart within the chest cavity, leading to a characteristic pattern of hemodynamic abnormalities. These include equalization of diastolic pressures in all cardiac chambers, increased systemic venous pressure, and decreased cardiac output.

The most common causes of constrictive pericarditis include prior infection, radiation therapy, autoimmune disorders, and previous heart surgery. Diagnosis typically involves a combination of medical history, physical examination, imaging studies such as echocardiography or MRI, and sometimes invasive testing such as cardiac catheterization. Treatment may involve medications to manage symptoms and reduce inflammation, as well as surgical removal of the pericardium (pericardiectomy) in severe cases.

Chyle is a milky, slightly opaque fluid that is present in the lymphatic system. It is formed in the small intestine during the digestion of food, particularly fats. Chyle consists of emulsified fat droplets (chylomicrons), proteins, electrolytes, and lymphocytes suspended in a watery solution. It is transported through the lacteals in the villi of the small intestine into the cisterna chyli and then to the thoracic duct, where it empties into the left subclavian vein. From there, it mixes with blood and circulates throughout the body. Chyle formation plays a crucial role in fat absorption and transportation in the human body.

Heart neoplasms are abnormal growths or tumors that develop within the heart tissue. They can be benign (noncancerous) or malignant (cancerous). Benign tumors, such as myxomas and rhabdomyomas, are typically slower growing and less likely to spread, but they can still cause serious complications if they obstruct blood flow or damage heart valves. Malignant tumors, such as angiosarcomas and rhabdomyosarcomas, are fast-growing and have a higher risk of spreading to other parts of the body. Symptoms of heart neoplasms can include shortness of breath, chest pain, fatigue, and irregular heart rhythms. Treatment options depend on the type, size, and location of the tumor, and may include surgery, radiation therapy, or chemotherapy.

The xiphoid process, also known as the xiphoid bone, is the smallest and lowest portion of the sternum or breastbone. It is located at the bottom tip of the sternum and has a shape that can be variable from person to person, ranging from elongated to almost square. The xiphoid process serves as an attachment point for several muscles, including the diaphragm, transverse abdominis, and oblique muscles. It also plays a role in the movement of the chest during respiration and other physical activities.

Otitis media with effusion (OME), also known as serous otitis media or glue ear, is a medical condition characterized by the presence of fluid in the middle ear without signs or symptoms of acute ear infection. The fluid accumulation occurs due to the dysfunction of the Eustachian tube, which results in negative pressure and subsequent accumulation of sterile fluid within the middle ear space.

OME can lead to hearing difficulties, especially in children, as the fluid buildup impairs sound conduction through the ossicles in the middle ear. Symptoms may include mild hearing loss, tinnitus (ringing in the ears), and a sensation of fullness or pressure in the affected ear. In some cases, OME can resolve on its own within a few weeks or months; however, persistent cases might require medical intervention, such as placement of tympanostomy tubes (ear tubes) to drain the fluid and restore hearing.

Echocardiography is a medical procedure that uses sound waves to produce detailed images of the heart's structure, function, and motion. It is a non-invasive test that can help diagnose various heart conditions, such as valve problems, heart muscle damage, blood clots, and congenital heart defects.

During an echocardiogram, a transducer (a device that sends and receives sound waves) is placed on the chest or passed through the esophagus to obtain images of the heart. The sound waves produced by the transducer bounce off the heart structures and return to the transducer, which then converts them into electrical signals that are processed to create images of the heart.

There are several types of echocardiograms, including:

* Transthoracic echocardiography (TTE): This is the most common type of echocardiogram and involves placing the transducer on the chest.
* Transesophageal echocardiography (TEE): This type of echocardiogram involves passing a specialized transducer through the esophagus to obtain images of the heart from a closer proximity.
* Stress echocardiography: This type of echocardiogram is performed during exercise or medication-induced stress to assess how the heart functions under stress.
* Doppler echocardiography: This type of echocardiogram uses sound waves to measure blood flow and velocity in the heart and blood vessels.

Echocardiography is a valuable tool for diagnosing and managing various heart conditions, as it provides detailed information about the structure and function of the heart. It is generally safe, non-invasive, and painless, making it a popular choice for doctors and patients alike.

Instillation, in the context of drug administration, refers to the process of introducing a medication or therapeutic agent into a body cavity or onto a mucous membrane surface using gentle, steady pressure. This is typically done with the help of a device such as an eyedropper, pipette, or catheter. The goal is to ensure that the drug is distributed evenly over the surface or absorbed through the mucous membrane for localized or systemic effects. Instillation can be used for various routes of administration including ocular (eye), nasal, auricular (ear), vaginal, and intra-articular (joint space) among others. The choice of instillation as a route of administration depends on the drug's properties, the desired therapeutic effect, and the patient's overall health status.

Heart injuries, also known as cardiac injuries, refer to any damage or harm caused to the heart muscle, valves, or surrounding structures. This can result from various causes such as blunt trauma (e.g., car accidents, falls), penetrating trauma (e.g., gunshot wounds, stabbing), or medical conditions like heart attacks (myocardial infarction) and infections (e.g., myocarditis, endocarditis).

Some common types of heart injuries include:

1. Contusions: Bruising of the heart muscle due to blunt trauma.
2. Myocardial infarctions: Damage to the heart muscle caused by insufficient blood supply, often due to blocked coronary arteries.
3. Cardiac rupture: A rare but life-threatening condition where the heart muscle tears or breaks open, usually resulting from severe trauma or complications from a myocardial infarction.
4. Valvular damage: Disruption of the heart valves' function due to injury or infection, leading to leakage (regurgitation) or narrowing (stenosis).
5. Pericardial injuries: Damage to the pericardium, the sac surrounding the heart, which can result in fluid accumulation (pericardial effusion), inflammation (pericarditis), or tamponade (compression of the heart by excess fluid).
6. Arrhythmias: Irregular heart rhythms caused by damage to the heart's electrical conduction system.

Timely diagnosis and appropriate treatment are crucial for managing heart injuries, as they can lead to severe complications or even be fatal if left untreated.

Artificial pneumothorax is a medical condition that is intentionally induced for therapeutic or diagnostic purposes. It involves the introduction of air or another gas into the pleural space, which is the potential space between the lungs and the chest wall. This results in the collapse of the lung on the side where the air was introduced, creating negative pressure that can help to relieve certain medical conditions.

Artificial pneumothorax is typically used as a treatment for pulmonary tuberculosis, although its use has become less common with the advent of more effective antibiotics and other treatments. It may also be used in rare cases to help collapse a lung that has been damaged or injured, making it easier to remove or repair.

The procedure for creating an artificial pneumothorax involves inserting a needle or catheter into the pleural space and introducing air or another gas. This can be done through the chest wall or through a tube that has been inserted into the lung. The amount of air introduced is carefully controlled to avoid over-inflation of the pleural space, which can cause complications such as tension pneumothorax.

While artificial pneumothorax is a useful medical procedure in certain circumstances, it carries risks and should only be performed by trained medical professionals in a controlled setting.

Thoracic radiography is a type of diagnostic imaging that involves using X-rays to produce images of the chest, including the lungs, heart, bronchi, great vessels, and the bones of the spine and chest wall. It is a commonly used tool in the diagnosis and management of various respiratory, cardiovascular, and thoracic disorders such as pneumonia, lung cancer, heart failure, and rib fractures.

During the procedure, the patient is positioned between an X-ray machine and a cassette containing a film or digital detector. The X-ray beam is directed at the chest, and the resulting image is captured on the film or detector. The images produced can help identify any abnormalities in the structure or function of the organs within the chest.

Thoracic radiography may be performed as a routine screening test for certain conditions, such as lung cancer, or it may be ordered when a patient presents with symptoms suggestive of a respiratory or cardiovascular disorder. It is a safe and non-invasive procedure that can provide valuable information to help guide clinical decision making and improve patient outcomes.

Postpericardiotomy Syndrome (PPS) is a clinical entity that can occur after cardiac surgical procedures. It is characterized by the presence of pericardial effusion, pleural effusion, and/or inflammation of the serosal surfaces lining the heart and chest cavity (pericardium and pleura). The symptoms typically develop within 1-6 weeks after surgery and include fever, chest pain, and signs of fluid accumulation in the pericardial or pleural spaces.

The exact cause of PPS is not fully understood, but it is thought to be related to an immune response to the surgical trauma, leading to inflammation and increased production of cytokines and other mediators. The diagnosis of PPS is typically made based on clinical criteria, including the presence of fever, pleural or pericardial effusion, and evidence of inflammation. Treatment may include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, or colchicine to reduce inflammation and relieve symptoms. In severe cases, drainage of the effusions may be necessary.

Chromium compounds refer to combinations of the metallic element chromium with other chemical elements. Chromium is a transition metal that can form compounds in various oxidation states, but the most common ones are +3 (trivalent) and +6 (hexavalent).

Trivalent chromium compounds, such as chromium(III) chloride or chromium(III) sulfate, are essential micronutrients for human health, playing a role in insulin function and glucose metabolism. They are generally considered to be less toxic than hexavalent chromium compounds.

Hexavalent chromium compounds, such as chromium(VI) oxide or sodium dichromate, are much more toxic and carcinogenic than trivalent chromium compounds. They can cause damage to the respiratory system, skin, and eyes, and prolonged exposure has been linked to an increased risk of lung cancer.

It is important to note that while some chromium compounds have beneficial effects on human health, others can be highly toxic and should be handled with care. Exposure to hexavalent chromium compounds, in particular, should be minimized or avoided whenever possible.

Hemangiosarcoma is a type of cancer that arises from the cells that line the blood vessels (endothelial cells). It most commonly affects middle-aged to older dogs, but it can also occur in cats and other animals, as well as rarely in humans.

This cancer can develop in various parts of the body, including the skin, heart, spleen, liver, and lungs. Hemangiosarcomas of the skin tend to be more benign and have a better prognosis than those that arise internally.

Hemangiosarcomas are highly invasive and often metastasize (spread) to other organs, making them difficult to treat. The exact cause of hemangiosarcoma is not known, but exposure to certain chemicals, radiation, and viruses may increase the risk of developing this cancer. Treatment options typically include surgery, chemotherapy, and/or radiation therapy, depending on the location and stage of the tumor.

Diaphragmatic eventration is a medical condition where the diaphragm, the thin muscle that separates the chest and abdominal cavities and helps with breathing, is abnormally thin and weak. This can cause the diaphragm to move upwards into the chest cavity, which can lead to difficulty breathing and other respiratory symptoms.

In eventration, the affected portion of the diaphragm is usually elevated and may have a transparent or bluish appearance due to the lack of muscle tissue. This condition can be present at birth (congenital) or acquired later in life due to injury or illness.

Mild cases of diaphragmatic eventration may not cause any symptoms and may not require treatment. However, more severe cases may require surgery to repair the damaged diaphragm and improve respiratory function.

Thoracic surgery, video-assisted (VATS) is a minimally invasive surgical technique used to diagnose and treat various conditions related to the chest cavity, including the lungs, pleura, mediastinum, esophagus, and diaphragm. In VATS, a thoracoscope, a type of endoscope with a camera and light source, is inserted through small incisions in the chest wall to provide visualization of the internal structures. The surgeon then uses specialized instruments to perform the necessary surgical procedures, such as biopsies, lung resections, or esophageal repairs. Compared to traditional open thoracic surgery, VATS typically results in less postoperative pain, shorter hospital stays, and quicker recoveries for patients.

A fatal outcome is a term used in medical context to describe a situation where a disease, injury, or illness results in the death of an individual. It is the most severe and unfortunate possible outcome of any medical condition, and is often used as a measure of the severity and prognosis of various diseases and injuries. In clinical trials and research, fatal outcome may be used as an endpoint to evaluate the effectiveness and safety of different treatments or interventions.

Exudates and transudates are two types of bodily fluids that can accumulate in various body cavities or tissues as a result of injury, inflammation, or other medical conditions. Here are the medical definitions:

1. Exudates: These are fluids that accumulate due to an active inflammatory process. Exudates contain high levels of protein, white blood cells (such as neutrophils and macrophages), and sometimes other cells like red blood cells or cellular debris. They can be yellow, green, or brown in color and may have a foul odor due to the presence of dead cells and bacteria. Exudates are often seen in conditions such as abscesses, pneumonia, pleurisy, or wound infections.

Examples of exudative fluids include pus, purulent discharge, or inflammatory effusions.

2. Transudates: These are fluids that accumulate due to increased hydrostatic pressure or decreased oncotic pressure within the blood vessels. Transudates contain low levels of protein and cells compared to exudates. They are typically clear and pale yellow in color, with no odor. Transudates can be found in conditions such as congestive heart failure, liver cirrhosis, or nephrotic syndrome.

Examples of transudative fluids include ascites, pleural effusions, or pericardial effusions.

It is essential to differentiate between exudates and transudates because their underlying causes and treatment approaches may differ significantly. Medical professionals often use various tests, such as fluid analysis, to determine whether a fluid sample is an exudate or transudate.

Pleural Tuberculosis is a form of extrapulmonary tuberculosis (EPTB) that involves the infection and inflammation of the pleura, which are the thin membranes that surround the lungs and line the inside of the chest cavity. This condition is caused by the Mycobacterium tuberculosis bacterium, which can spread through the air when an infected person coughs, sneezes, or talks.

In pleural tuberculosis, the bacteria reach the pleura either through direct extension from a nearby lung infection or via bloodstream dissemination. The infection can cause the pleura to become inflamed and produce excess fluid, leading to pleural effusion. This accumulation of fluid in the pleural space can cause chest pain, coughing, and difficulty breathing.

Diagnosis of pleural tuberculosis typically involves a combination of medical history, physical examination, imaging studies such as chest X-rays or CT scans, and laboratory tests such as acid-fast bacilli (AFB) smear microscopy, culture, and nucleic acid amplification tests (NAATs) to detect the presence of M. tuberculosis in the pleural fluid or tissue samples.

Treatment of pleural tuberculosis typically involves a standard course of anti-tuberculosis therapy (ATT), which includes a combination of multiple antibiotics such as isoniazid, rifampin, ethambutol, and pyrazinamide. The duration of treatment may vary depending on the severity of the infection and the patient's response to therapy. In some cases, surgical intervention may be necessary to drain the pleural effusion or remove the infected pleura.

Primary effusion lymphoma (PEL) is a rare type of non-Hodgkin lymphoma that typically presents as an effusion (accumulation of fluid) in the pleural, pericardial, or peritoneal cavities without a detectable tumor mass. It is strongly associated with the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) and often occurs in people with weakened immune systems, such as those with HIV/AIDS. The malignant cells in PEL are typically large B-cells that secrete fluid, leading to the formation of effusions. This type of lymphoma is aggressive and has a poor prognosis.

Pyrantel pamoate is an anthelmintic medication used to treat intestinal worm infections, such as pinworms, roundworms, and hookworms. It works by paralyzing the adult worms, which are then expelled from the body through the natural digestive process.

Pyrantel pamoate is available over-the-counter in various forms, including tablets, chewable tablets, and suspensions. The medication is typically taken as a single dose, but it may be repeated after two weeks for some types of worm infections.

It's important to note that while pyrantel pamoate can effectively treat intestinal worm infections, it does not prevent reinfection. Therefore, good hygiene practices, such as washing hands regularly and avoiding contact with contaminated soil or feces, are essential to reduce the risk of re-infection.

As with any medication, pyrantel pamoate should be taken under the guidance of a healthcare professional, especially in children, pregnant women, and people with certain medical conditions or who are taking other medications.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

Pleurisy is a medical condition characterized by inflammation of the pleura, which are the thin membranes that surround the lungs and line the inside of the chest cavity. The pleura normally produce a small amount of lubricating fluid that allows for smooth movement of the lungs during breathing. However, when they become inflamed (a condition known as pleuritis), this can cause pain and difficulty breathing.

The symptoms of pleurisy may include sharp chest pain that worsens with deep breathing or coughing, shortness of breath, cough, fever, and muscle aches. The pain may be localized to one area of the chest or may radiate to other areas such as the shoulders or back.

Pleurisy can have many different causes, including bacterial or viral infections, autoimmune disorders, pulmonary embolism (a blood clot that travels to the lungs), and certain medications or chemicals. Treatment typically involves addressing the underlying cause of the inflammation, as well as managing symptoms such as pain and breathing difficulties with medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) or opioids. In some cases, more invasive treatments such as thoracentesis (removal of fluid from the chest cavity) may be necessary.

A diverticulum is a small sac or pouch that forms as a result of a weakness in the wall of a hollow organ, such as the intestine. These sacs can become inflamed or infected, leading to conditions like diverticulitis. Diverticula are common in the large intestine, particularly in the colon, and are more likely to develop with age. They are usually asymptomatic but can cause symptoms such as abdominal pain, bloating, constipation, or diarrhea if they become inflamed or infected.

No FAQ available that match "pericardial effusion"

No images available that match "pericardial effusion"